Australian Regulator: Don't Let New Ingredient Name Deadline Sneak Up On You
The Therapeutic Goods Administration is urging companies to update their medicine labels and documentation with new ingredient names.
You may also be interested in...
The Therapeutic Goods Administration says consumers are frustrated that they cannot easily access information on excipient ingredients through existing mechanisms.
Health technology assessment body NICE is consulting on draft guidance that recommends Axonics' device for overactive bladder.
The risk of developing meningioma with cyproterone-containing medicines is rare, but it is serious enough to merit restrictions on how such products are used, according to the European Medicines Agency.